Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily
about
Pharmacokinetics and pharmacodynamics of aerosolized antibacterial agents in chronically infected cystic fibrosis patients.Quantification of amikacin in bronchial epithelial lining fluid in neonates.Delivering antibacterials to the lungs: considerations for optimizing outcomes.Amikacin Pharmacokinetics/Pharmacodynamics in a Novel Hollow-Fiber Mycobacterium abscessus Disease Model.Failure of the Amikacin, Cefoxitin, and Clarithromycin Combination Regimen for Treating Pulmonary Mycobacterium abscessus Infection.Amikacin Optimal Exposure Targets in the Hollow-Fiber System Model of TuberculosisAerosol delivery during invasive mechanical ventilation: a systematic review.BAY41-6551 achieves bactericidal tracheal aspirate amikacin concentrations in mechanically ventilated patients with Gram-negative pneumonia.Lung tissue concentrations of nebulized amikacin during mechanical ventilation in piglets with healthy lungs.Prolonged use of carbapenems and colistin predisposes to ventilator-associated pneumonia by pandrug-resistant Pseudomonas aeruginosa.NKTR-061 (inhaled amikacin) delivers high lung doses in mechanically ventilated patients with pneumonia and in healthy subjects.Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
P2860
Q34297656-EF91B153-F833-45BC-9285-CDEE7E2BE1D0Q35191478-8BF9C0E2-B931-4AE7-AFD3-6944DEC04DA5Q35627814-0776953F-ADAA-419A-917B-4170F6F025E1Q36644647-CB1F1081-3398-49C0-9258-660F4D0522C4Q37287641-6B632186-638A-48B2-9D23-50E219842BBCQ37287830-6A230ADA-2307-4AF5-853A-A30B1AA752D5Q42654272-1AFC7F4C-7CC2-4AED-B54E-FDF695C2C9D2Q43700878-679E5804-6438-43AC-A589-D490B1D611B3Q43854253-2F53DEB5-0B13-4EF9-BC61-7B7DD3D71D9DQ44251526-BC910C0D-1DAC-4DCD-ADC4-2D031EF1D08AQ45765090-C871B396-2D2B-41DF-BFCC-C52E1ECFD610Q53750484-8BE4608F-EE3F-4193-8FA2-580D48533661
P2860
Amikacin levels in bronchial secretions of 10 pneumonia patients with respiratory support treated once daily versus twice daily
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Amikacin levels in bronchial s ...... once daily versus twice daily
@ast
Amikacin levels in bronchial s ...... once daily versus twice daily
@en
type
label
Amikacin levels in bronchial s ...... once daily versus twice daily
@ast
Amikacin levels in bronchial s ...... once daily versus twice daily
@en
prefLabel
Amikacin levels in bronchial s ...... once daily versus twice daily
@ast
Amikacin levels in bronchial s ...... once daily versus twice daily
@en
P2093
P2860
P356
P1476
Amikacin levels in bronchial s ...... once daily versus twice daily
@en
P2093
Beaucaire G
Beuscart C
Jacquier JM
P2860
P304
P356
10.1128/AAC.39.1.264
P407
P577
1995-01-01T00:00:00Z